Bradley C. Graveline

Bradley C. Graveline is a Partner at Sheppard, Mullin, Richter & Hampton LLP, where he also co-leads the firm's Cannabis Industry Team. His patent litigation practice spans over 30 years, focusing on complex infringement cases across diverse technologies including pharmaceuticals, biologics, medical devices, nutrition supplements, security screening systems, computer software, and wireless communications. Graveline notably represents patent holders in asserting their rights, exemplified by his work for SecurityPoint Holdings Inc., and also handles Hatch-Waxman (ANDA) litigation for generic pharmaceutical manufacturers, challenging brand-name drug patents.

A significant achievement in his career includes leading the trial team that secured the largest-ever patent infringement damages award against the U.S. government for SecurityPoint Holdings Inc. This case resulted in an award of over $170 million in 2025 for the unauthorized use of SecurityPoint's patent covering methods for managing trays at airport security checkpoints. He also possesses extensive experience in life sciences patent litigation, having represented pharmaceutical companies like Barr Laboratories in more than 25 ANDA cases related to products such as raloxifene, oral contraceptives, and drugs for attention deficit disorders and inflammatory bowel disease. No information regarding his regular appearance in PTAB or IPR proceedings was found.

Mr. Graveline was admitted to practice in Illinois in 1990, the same year he earned his Juris Doctor from Northwestern University School of Law. Beyond patent litigation, his practice encompasses trademark infringement disputes, trademark prosecution and management, and advising cannabis sector clients on intellectual property and regulatory matters.